Mapping/Ablation

EP Lab Digest speaks with Ali Al-Mudamgha, MD, about the successful completion of 1000 Watchman device (Boston Scientific) procedures earlier this year at St. Joseph's Health Cardiovascular Institute—an important milestone in the growth of...

For the first time, we now have data from a prospective, randomized, controlled trial directly comparing rivaroxaban and apixaban.

Melissa May, MSN, RN, describes the successful completion of the initial pulsed field ablation (PFA) cases for atrial fibrillation (AF) at WellSpan Ephrata Community Hospital in Ephrata, Pennsylvania.

Douglas Y Mah, MD, FHRS, CEPS-P, discusses long-term consequences of lead management decisions in pediatric and congenital heart disease patients, leadless pacing and nonvascular ICD technologies for younger patients, and the unanswered...

After reaching the milestone of 1500 LAAO procedures, Thabet Alsheikh, MD, shares the operational, clinical, and patient care strategies that have helped Baptist Health Care build a high-volume, high-performing LAAO program.

As cardiovascular implantable electronic device (CIED) technology continues to evolve, so too does the complexity of lead management and extraction. The 2026 HRS Expert Consensus Statement underscores the importance of multidisciplinary care,...

Nadine Wlasiuk, DNP, APRN, highlights the vital role of APPs in expanding access, improving efficiency, and strengthening continuity of care in EP.

Stephen Gaeta, MD, PhD, of Inova Health System—one of the largest EP programs in the nation, discusses the impact of adopting the Affera™ mapping and ablation system (Medtronic) across a high-volume EP practice.

In this month’s editorial, we present a renewed, combined set of “10 commandments” for incoming and graduating EP fellows—timeless principles that continue to hold true.